Prudential Financial
PGNX

Prudential Financial’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Prudential Financial’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-133,192
Closed -$506K – 2512
2020
Q1 		$506K Sell
133,192
-788
-0.6% -$3.4K ﹤0.01% 1907
2019
Q4 		$682K Buy
133,980
+450
+0.3% +$2.38K ﹤0.01% 1978
2019
Q3 		$674K Sell
133,530
-156
-0.1% -$778 ﹤0.01% 1963
2019
Q2 		$825K Buy
133,686
+893
+0.7% +$4.3K ﹤0.01% 1937
2019
Q1 		$616K Buy
132,793
+381
+0.3% +$1.72K ﹤0.01% 2031
2018
Q4 		$556K Sell
132,412
-3,880
-3% -$19.8K ﹤0.01% 1977
2018
Q3 		$855K Buy
136,292
+13,790
+11% +$106K ﹤0.01% 1909
2018
Q2 		$985K Buy
122,502
+8,140
+7% +$62.1K ﹤0.01% 1904
2018
Q1 		$853K Buy
114,362
+1,800
+2% +$12K ﹤0.01% 1892
2017
Q4 		$670K Sell
112,562
-2,240
-2% -$13.6K ﹤0.01% 1940
2017
Q3 		$845K Sell
114,802
-570
-0.5% -$3.62K ﹤0.01% 1894
2017
Q2 		$783K Sell
115,372
-12,600
-10% -$93K ﹤0.01% 1916
2017
Q1 		$1.21M Buy
+127,972
New +$1.28M ﹤0.01% 1784
2014
Q3 		– Sell
-13,245
Closed -$57K – 2351
2014
Q2 		$57K Buy
13,245
+193
+1% +$737 ﹤0.01% 2379
2014
Q1 		$53K Buy
13,052
+400
+3% +$2.05K ﹤0.01% 2230
2013
Q4 		$67K Sell
12,652
-1,700
-12% -$7.48K ﹤0.01% 2247
2013
Q3 		$72K Sell
14,352
-600
-4% -$3.25K ﹤0.01% 2234
2013
Q2 		$67K Buy
+14,952
New +$67.1K ﹤0.01% 2244

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Prudential Financial's PGNX Position: Q2 2020 in Review

Prudential Financial sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 133,192 shares — an estimated $506K sold.

Prudential Financial first reported a position in PGNX in Q2 2013 and held it in 18 quarters. The position peaked at $1.21M in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Prudential Financial reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Prudential Financial sold 133,192 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $506K.
  • Prudential Financial first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
  • Prudential Financial's Progenics Pharmaceuticals Inc position peaked at $1.21M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Prudential Financial's 13F filing for Q2 2020, filed 12 Aug 2020.